How Semerjian was paid
$10.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Harout SemerjianPresident and Chief Executive Officer | $321,538 | — | — | $9,695,400 | $203,000 | $1,817 | $10,221,755 |
| John A. Scarlett, M.D.Former Chairman of the Board, President and Chief Executive Officer | $309,781 | — | $1,078,300 | $4,308,104 | — | $1,726,569 | $7,422,754 |
| Dawn C. BirFormer Interim President and Chief Executive Officer | $318,190 | — | — | $163,674 | — | $40,258 | $522,122 |
| Michelle J. RobertsonExecutive Vice President, Finance, Chief Financial Officer, Treasurer and Interim Secretary | $559,800 | — | $289,300 | $1,150,230 | $239,300 | $11,452 | $2,250,082 |
| Ahmed ElNawawiExecutive Vice President, Chief Commercial Officer | $107,692 | $200,000 | — | $2,573,400 | — | $242 | $2,881,334 |
| Joseph Eid, M.D.Executive Vice President, Research & Development, Chief Medical Officer | $650,000 | — | — | — | $339,600 | $11,452 | $1,001,052 |
| Andrew J. Grethlein, Ph.D.Former Executive Vice President, Chief Operating Officer | $563,276 | — | $368,200 | $1,474,253 | — | $910,715 | $3,316,444 |
| James ZieglerFormer Executive Vice President, Chief Commercial Officer | $470,028 | — | $234,070 | $927,549 | — | $761,062 | $2,392,709 |
What changed and why
- Harout Semerjian received 10,221,755 in total compensation following his appointment as President and Chief Executive Officer on August 7, 2025.
- John A. Scarlett received 7,422,754 in total compensation for 2025 prior to his departure as Chief Executive Officer.
- Ahmed ElNawawi received a 200,000 sign-on bonus upon joining the Company as Executive Vice President, Chief Commercial Officer.
- The ratio of the CEO annualized total compensation to the median employee total compensation was 35 to 1.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.